Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POMALIDOMIDE vs PONATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POMALIDOMIDE vs PONATINIB: Safety Overview

Metric POMALIDOMIDE PONATINIB
Total FAERS Reports 92,291 10,011
Deaths Reported 12,672 2,924
Death Rate 13.7% 29.2%
Hospitalizations 24,801 4,254
Average Patient Age 69.9 yrs 55.8 yrs
% Female Patients 49.2% 46.2%
FDA Approval Date Feb 8, 2013 Apr 23, 2015
Manufacturer Celgene Corporation Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription